Ads
related to: Pfizer
Search results
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
NBC Universal via AOL· 2 hours agoThe Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 3 hours agoBeyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of...
US approves gene therapy treatment for hemophilia
Medical Xpress· 41 minutes agoPharmaceutical giant Pfizer has received US approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the...
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 5 hours agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
Travis Kelce's dad's three-word response to Taylor Swift marriage claim
Newsweek· 6 hours agoTravis Kelce's father has shared his thoughts on a marriage rumor surrounding his son and Taylor...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 3 hours agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 5 hours agoThe Food and Drug Administration approval of Beqvez comes as other gene therapies for the bleeding...
Pfizer Receives FDA Approval for Bleeding Disorder Treatment
Barrons.com· 2 hours agoPfizer has received approval from the Food and Drug Administration for a rare genetic bleeding...
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 8 hours agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron...
Pfizer's Options: A Look at What the Big Money is Thinking - Pfizer (NYSE:PFE)
Benzinga· 2 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...